Journal article
Acceptability and feasibility of biomarkers of airway eosinophilic inflammation for the management of preschool wheeze: a qualitative study
- Abstract:
- Objective: This study aimed to examine whether biomarker tests—finger-prick, skin-prick and offline fractional exhaled nitric oxide (FeNO)—are acceptable and feasible as a guide to treatment decisions, uniquely combining the perspectives of parents of preschool children with wheeze and healthcare professionals (HCPs) working in National Health Service (NHS) primary care. Design: Qualitative interview study. Criterion sampling was used to recruit 16 parents from 16 families, and convenience sampling to recruit 16 HCPs (doctors and nurses) from 14 primary care NHS practices. Qualitative data were collected via online one-to-one interviews and focus groups (FGs), conducted on Microsoft Teams, transcribed and thematically analysed within the NVivo software package. Results: Parents described the biomarker tests as acceptable when they were supported by evidence of effectiveness and empathetic communication from HCPs. Skin-prick testing was the most preferred test by parents as it helped them minimise allergen exposures. HCPs favoured finger-prick and FeNO tidal breathing test due to greater familiarity and feasibility in primary care. Time constraints, cost of devices and training to perform the biomarker tests were reported as barriers to implementation. Both groups agreed that testing frequency should depend on wheeze severity. Finally, a proposed future randomised controlled trial examining whether a biomarker-based approach is superior to the current symptom-based approach was regarded as acceptable and feasible. Conclusion: Finger-prick, skin-prick and FeNO testing are conditionally acceptable and feasible in clinical practice for preschool wheeze. However, there should be evidence of their effectiveness, empathetic communication between parents and HCPs and tests’ cost-effectiveness to support NHS funding.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 351.0KB, Terms of use)
-
- Publisher copy:
- 10.1136/archdischild-2025-329433
Authors
+ Asthma UK Centre for Applied Research
More from this funder
- Funder identifier:
- https://ror.org/04ect1284
- Publisher:
- BMJ Publishing Group
- Journal:
- Archives of Disease in Childhood More from this journal
- Article number:
- archdischild-2025-329433
- Publication date:
- 2025-12-20
- Acceptance date:
- 2025-11-27
- DOI:
- EISSN:
-
1468-2044
- ISSN:
-
0003-9888
- Language:
-
English
- Keywords:
- Pubs id:
-
2353868
- UUID:
-
uuid_bc631967-6fb7-4734-bb0a-5025fc499ded
- Local pid:
-
pubs:2353868
- Source identifiers:
-
3585376
- Deposit date:
-
2025-12-22
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from BMJ Publishing Group at https://doi.org/10.1136/archdischild-2025-329433
If you are the owner of this record, you can report an update to it here: Report update to this record